SUPERGLUTIDE

Serial Number 98262472
731

Registration Progress

Application Filed
Nov 9, 2023
Under Examination
Oct 8, 2024
Approved for Publication
Aug 13, 2024
Published for Opposition
Aug 13, 2024
Registered

Attorney Assistance

Statement of Use Due - Extension 2 Granted
Due: Apr 08, 2026 151 days

Trademark Image

SUPERGLUTIDE

Basic Information

Serial Number
98262472
Filing Date
November 9, 2023
Published for Opposition
August 13, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
731
Status Date
Sep 29, 2025
Application
Pending
Classes
005

Rights Holder

Adonis Health, Inc.

03
Address
1980 Festival Plaza Dr. #300
Las Vegas, NV 89135

Ownership History

Adonis Health, Inc.

Original Applicant
03
Las Vegas, NV

Adonis Health, Inc.

Owner at Publication
03
Las Vegas, NV

Legal Representation

Attorney
Emily Poole

USPTO Deadlines

Next Deadline
151 days remaining
Statement of Use Due - Extension 2 Granted
Due Date
April 08, 2026
Extension Available
Until October 08, 2025

Application History

23 events
Date Code Type Description Documents
Sep 30, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 29, 2025 EX2G S SOU EXTENSION 2 GRANTED Loading...
Sep 29, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 29, 2025 EXT2 S SOU EXTENSION 2 FILED Loading...
Feb 4, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Feb 4, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 3, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Feb 3, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 8, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 13, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 13, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 24, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 2, 2024 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jul 2, 2024 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jul 2, 2024 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jul 2, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 2, 2024 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Jun 14, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 14, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 14, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 10, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 11, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 13, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceuticals for weight loss and weight management; pharmaceutical preparations and substances for the treatment of metabolic diseases and disorders; compounded medications for use in weight management; the foregoing containing glucagon-like peptide analogs.

Classification

International Classes
005